Compounds and methods for inhibiting JAK

HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

Blocking toll-like receptor 9 signaling with small molecule antagonist

Phosphonate compounds for treatment of complement mediated disorders

Heterocyclic compound, and organic electroluminescence device and organic electroluminescence display device including the same

Substituted pyrimidines as LRKK2 inhibitors

METHOD FOR PRODUCING NITROGEN-CONTAINING AROMATIC AMIDE, METHOD FOR PRODUCING PYRROLE-IMIDAZOLE POLYAMIDE, AND COMPOUND

(Alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases

Organic electroluminescent materials and devices

Compositions and methods for treating infections

Bisamide sarcomere activating compounds and uses therof

Imide derivatives and use thereof as medicine

Thermally activated delayed fluorescence material and application thereof in organic electroluminescence device

Organic compound with triazine and benzimidazole as core and application thereof in organic electroluminescent device

MULTIPLE-FUNCTIONAL PROBE AND USES THEREOF

Pyrrolobenzodiazepines and conjugates thereof

Organic light-emitting device

Organic light-emitting device

Ether compounds and uses thereof

Compounds and methods of use thereof for treatment of cancer

Covalent inhibitors of KRAS

Organic molecules, in particular for use in optoelectronic devices

Quinoxaline and pyridopyrazine derivatives as PI3Kβ inhibitors

Heterocycle and carbocycle derivatives having TRKA inhibitory activity

Heterocycle-substituted bicyclic azole pesticides

Inhibitors of lysine specific demethylase-1

Compositions and methods for inhibiting kinases

Compounds

Indole derivatives and uses thereof

Organic electroluminescent materials and devices

Ether compounds for treatment of complement mediated disorders

Nitrogen-containing heterocycle and carbocycle derivatives having TrkA inhibitory activity

Substituted pyrazin-2-amines as inhibitors of ATR kinase

Benzolactam compounds as protein kinase inhibitors

Aryl substituted pyrimidines for use in influenza virus infection

Substituted imidazolylcarboxamides as pesticides

Substituted 2-(het)arylimidazolylcarboxyamides as pesticides

NOVEL COMPOUND AND PHARMACOLOGICALLY ACCEPTABLE SALT THEREOF

Urea compound, preparation method therefor and medical use thereof

Heterocyclic compound and organic electroluminescence device including the same

Biaryl kinase inhibitors

EGFR Inhibitors and Methods of Treating Disorders

Branched multi-functional macromonomers and uses thereof

Compounds for treatment of complement mediated disorders

Benzamide and nicotinamide compounds and methods of using same

GLS1 inhibitors for treating disease

Pyrimidine compound and pharmaceutical use thereof

PYRAZOLE DERIVATIVES AS SGC STIMULATORS

Therapeutic compounds and methods of use thereof

Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disorders

Broad spectrum antibacterial activity of novel bisbenzimidazoles targeting topoisomerase IA and the synergistic composition of bisbenzimidazole with efflux pump inhibitors against pathogenic bacteria

Quinoxalinones and dihydroquinoxalinones as respiratory syncytial virus antiviral agents

Selective inhibitors of clinically important mutants of the EGFR tyrosine kinase

Quinolin-2-one derivatives

Heterocyclic compounds as adenosine antagonists

Organic electroluminescence element, and material for organic electroluminescence element

Organic molecules, in particular for use in optoelectronic devices

Indolin-2-one and 1,3-dihydro-pyrrolo[3,2-c]pyridin-2-one derivatives

Small molecule IRE1-α inhibitors

Compound, light-emitting material, and organic light-emitting device

Anti-Viral Compounds

Compound for organic-electric element, organic-electric element using same, and electronic device for same

Factor XIa macrocycle inhibitors bearing a non-aromatic P2' group

Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof

2-cyanoisoindoline derivatives for treating cancer

Metalloenzyme inhibitor compounds

Inhibitors of hepatitis C virus

ORGANIC FUNCTIONAL COMPOUND FOR PREPARING ORGANIC ELECTRONIC DEVICE AND APPLICATION THEREOF

Organic light emitting element

Organic molecules, in particular for use in optoelectronic devices

Benzimidazolo[1,2-a]benzimidazole derivatives for organic light emitting diodes

Rho-associated protein kinase inhibitor, pharmaceutical composition comprising the same, as well as preparation method and use thereof

6-hydroxy-4-oxo-1,4-dihydropyrimidine-5-carboxamides as APJ agonists

Methods for treating Huntington's disease

Organic compounds

Tank-binding kinase inhibitor compounds

Organic molecules, in particular for use in optoelectronic devices

Inhibiting agents for Bruton's tyrosine kinase

Pharmaceutical compounds

INDOLE COMPOUNDS AND PHARMACEUTICAL USE THEREOF

Methods for inducing bioorthogonal reactivity

Pyrrolidine derivatives

SELECTIVELY SUBSTITUTED QUINOLINE COMPOUNDS

TERBENZOCYCLOPENTADIENE COMPOUND, HIGH POLYMER, MIXTURE, COMPOSITION AND ORGANIC ELECTRONIC DEVICE

Carbazole derivative and organic light emitting device using same

Anti-cancer compounds

Pharmaceutical compound

Heterocyclic compounds and uses thereof

Trk inhibition

PYRAZOLE COMPOUND AND PHARMACEUTICAL USE THEREOF

Organic electroluminescent materials and devices

AZASPIRO DERIVATIVES AS TRPM8 ANTAGONISTS

Pyrazole MAGL inhibitors

Light-emitting element, light-emitting device, electronic device, lighting device, and organic compound

Substituted 1,2,3-triazoles as NR2B-selective NMDA modulators

Pyrrolidinyl urea, pyrrolidinyl thiourea and pyrrolidinyl guanidine compounds as TrkA kinase inhibitors

Compositions, methods of use, and methods of treatment

Pyrrolotriazine compounds as TAM inhibitors

Pyrazole compounds and methods of making and using same

IMIDAZOLIN-5-ONE DERIVATIVE USEFUL AS FASN INHIBITORS FOR THE TREATMENT OF CANCER

Compound, compositions, and methods

Apoptosis signal-regulating kinase 1 inhibitors and methods of use thereof

Aminopyrazine compounds with A2A antagonist properties

Inhibitors of lysine specific demethylase-1

Use of maleimide derivatives for preventing and treating cancer

Pyrazolylaminobenzimidazole derivatives as JAK inhibitors

Selective octahydro-cyclopenta[c]pyrrole negative modulators of NR2B

Ferroportin inhibitors

Inhibitors of KRAS G12C mutant proteins

Inhibitors of cyclin-dependent kinase 7 (CDK7)

Benzopiperazine compositions as BET bromodomain inhibitors

Antibiotic Compounds, Pharmaceutical Formulations Thereof And Methods And Uses Therefor

Bipyrazole derivatives as JAK inhibitors

Selective NR2B antagonists

Substituted indazole compounds as RORgammaT inhibitors and uses thereof

Substituted benzofuran, benzothiophene and indole Mcl-1 inhibitors

DNA-PK INHIBITORS

Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disorders

ALPHA HELIX MIMETICS AND METHODS RELATING THERETO

Inhibitors of bruton's tyrosine kinase

Disubstituted 1, 2, 4-triazine compound

EBNA1 inhibitors and methods using same

SMAC mimetic

Combination therapy for treating malignancies

SUBSITUTED ALIPHANES, CYCLOPHANES, HETERAPHANES, HETEROPHANES, HETERO-HETERAPHANES AND METALLOCENES USEFUL FOR TREATING HCV INFECTIONS

Alkyne Compounds for Treatment of Complement Mediated Disorders

Inhibiting agents for bruton's tyrosine kinase

Ferroportin inhibitors

Benzoimidazole derivatives as PAD4 inhibitors

Substituted pyrrolidines as G-protein coupled receptor 43 agonists

2,2′-bibenzo[D]imidazolidene compound having heteromonocyclic groups at the 1-, 1′-, 3- and 3′- positions, and organic light-emitting element and display device containing the same

Dopant for organic optoelectronic device, organic optoelectronic device, and display device

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

ALKYNE COMPOUNDS FOR TREATMENT OF COMPLEMENT MEDIATED DISORDERS

Certain protein kinase inhibitor

Substituted 6a,7,8,9,10,12-hexahydrobenzo[e]pyrido[1,2-a][1,4]diazepines as anti-proliferative agents

Benzimidazole derivatives as ERBB tyrosine kinase inhibitors for the treatment of cancer

Aryl-substituted imidazoles

BRD4-kinase inhibitors as cancer therapeutics

Inhibitors of EGFR and methods of use thereof

Lanthionine synthetase C-like 2-based therapeutics

Substituted indazole derivatives active as kinase inhibitiors

Azetidine-substituted fluorescent compounds

Biaryl pyrazoles as NRF2 regulators

Salt of pyrrolo[2,3-D]pyrimidine compound and novel polymorph of salt

Dopamine D3 receptor antagonists

FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Kinase inhibitors and method of treating cancer

Arylcyclohexyl pyrazoles as NRF2 regulators

SUBSTITUTED HETEROCYCLIC SULFONAMIDE COMPOUNDS USEFUL AS TRPA1 MODULATORS

Composition, organic-electroluminescence-device material, composition film, organic electroluminescence device, and electronic device

Compound and organic electronic device comprising same

Inhibitors of KRAS G12C mutant proteins

Inhibitors of KRAS G12C mutant proteins

Dicyanopyrazine compound, luminescent material, luminescence device using the same, and method for producing 2,5-dicyano-3,6-dihalogenopyrazine

Heterocyclic compound and pharmaceutical composition comprising same

THERAPEUTIC COMPOUNDS

Pharmaceutical compounds

N4-phenyl-quinazoline-4-amine derivatives and related compounds as ErbB type I receptor tyrosine kinase inhibitors for the treatment of hyperproliferative diseases

Triphenylene-based materials for organic electroluminescent devices

Marinopyrrole derivatives and methods of making and using same

Apelin receptor (APJ) agonists and uses thereof

Amide-substituted heterocyclic compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responses

Biaryl piperidine amide compounds and methods of use thereof

Inhibitors of lysine specific demethylase-1

Therapeutic compounds and methods of use thereof

Pesticidally active pyrazole derivatives

Process for the preparation of Daclatasvir dihydrochloride and its intermediates

Substituted imidazoles as melanocortin receptor agonists

Heterocyclic bridged biphenyls

5-[(piperazin-1-yl)-3-oxo-propyl]-imidazolidine-2,4-dione derivatives as ADAMTS inhibitors for the treatment of osteoarthritis

Urinary polyamines as prostate cancer detection biomarkers

1,5-disubstituted 1,2,3-triazoles are inhibitors of RAC/CDC42 GTPases

Histone demethylase inhibitors

Indolin-2-one derivatives

Indolin-2-one derivatives

Indolin-2-one derivatives

Indolin-2-one derivatives

1,3-SUBSTITUTED PYRAZOLE COMPOUNDS USEFUL FOR REDUCTION OF VERY LONG CHAIN FATTY ACID LEVELS

Protein kinase inhibitors

Organic electroluminescent materials containing benzimidazole and organic electroluminescent device by using the same

Condensed cyclic compound and organic light-emitting device including the same

LACTAM-CONTAINING COMPOUNDS AND DERIVATIVES THEREOF AS FACTOR XA INHIBITORS

Pyrazol-3-ones that activate pro-apoptotic BAX

Rho kinase inhibitors

Metallo-beta-lactamase inhibitors

Fluoroindole derivatives as muscarinic M1 receptor positive allosteric modulators

Substituted aromatic n-heterocyclic compounds as inhibitors of mitogen-activated protein kinase interacting kinase 1 (MNK1) and 2 (MNK2)

HIGHLY SENSITIVE DETECTION OF BIOMOLECULES USING PROXIMITY INDUCED BIOORTHOGONAL REACTIONS

Heterocyclic compound and organic light emitting element using same

Compositions and methods for the production of pyrimidine and pyridine compounds with BTK inhibitory activity

Amino pyrazine derivatives as phosphatidylinositol 3-kinase inhibitors

Azetidine compounds as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders

Modulators of estrogen receptor proteolysis and associated methods of use

Organic electroluminescent compound and an organic electroluminescent device comprising the same

Chimeric compounds targeting proteins, compositions, methods, and uses thereof

Compounds inhibiting leucine-rich repeat kinase enzyme activity

5-(N-fused tricyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Piperazine derivative

NOVEL INHIBITOR COMPOUNDS OF PHOSPHODIESTERASE TYPE 10A

Bis-heteroaryl derivatives as modulators of protein aggregation

Modulators of calcium release-activated calcium channel

Compounds for use in preparing heterocyclic triazole agonists of the APJ receptor

HETEROAROMATIC COMPOUNDS AS BTK INHIBITORS

Heterocyclic modulators of lipid synthesis

3-(1H-indol-2-yl)-1H-indazoles and therapeutic uses thereof

5-(n-[6,5]-fused bicyclic aryl tetrahydroisoquinolin-6-yl) pyridin-3-yl acetic acid derivatives as inhibitors of human immunodeficiency virus replication

Substituted glycine derived FXIA inhibitors

Vinyl compounds as FGFR and VEGFR inhibitors

Metalloenzyme inhibitor compounds

Pyridazine derivatives as RORc modulators

SecA INHIBITORS AND METHODS OF MAKING AND USING THEREOF

Indazole Derivatives as Modulators of TNF Activity

3-indol substituted derivatives, pharmaceutical compositions and methods for use

Factor XIa macrocyclic inhibitors bearing alkyl or cycloalkyl P2' moieties

Substituted quinazoline compounds and preparation and uses thereof

Bisamidinium-based inhibitors for the treatment of myotonic dystrophy

PYRIMIDINE DERIVATIVES AS KINASE INHIBITORS AND THEIR THERAPEUTICAL APPLICATIONS

BENZOIMIDAZOLES AS PROLYL HYDROXYLASE INHIBITORS

Azolopyrimidine for the treatment of cancer-related disorders

Dopant for organic optoelectronic device, organic optoelectronic device and display device

ORGANIC ELECTROLUMINESCENT ELEMENT

ORGANIC LIGHT-EMITTING DIODE MATERIALS

Organic electroluminescent device, thin luminous film, display apparatus, and lighting apparatus

Organic electroluminescence device

Compounds, compositions, and methods

DNA-PK inhibitors

TRIAZOLE COMPOUND

3-((Hetero-)Aryl)-8-Amino-2-Oxo-1,3-Diaza-Spiro-[4.5]-Decane Derivatives

INDAZOLE AND AZAINDAZOLE COMPOUNDS AS IRAK-4 INHIBITORS

Heterocycle derivatives having TrkA inhibitory activity

Compounds for treatment of immune inflammatory disorders

Nitrogen-containing compounds suitable for use in the production of polyurethanes

Pyrimidines as EGFR inhibitors and methods of treating disorders

Ledipasvir crystal form and preparation method thereof

Substituted pyrazoles as inhibitors of fibroblast growth factor receptor

Compounds for the treatment of HIV

Cyanopyrrolidines as dub inhibitors for the treatment of cancer

DNA-PK inhibitors

Luminescent material for delayed fluorescence and organic electroluminescent device comprising the same

Inhibitors of protein kinases

Amide compounds for treatment of immune and inflammatory disorders

Quinoxaline derivatives useful as FGFR kinase modulators

LYSYL OXIDASE-LIKE 2 INHIBITORS AND USES THEREOF

Diazirine compounds and compositions derived therefrom

Phthalazinone derivatives

Disubstituted compounds for treatment of medical disorders

Inhibitors of the TEC Kinase Enzyme Family

Inhibitors of lysine specific demethylase-1

SYNTHESIS OF A COMPOUND THAT MODULATES THE ACTIVITY OF BROMODOMAIN-CONTAINING PROTEINS

Metallo-β-lactamase inhibitors

ADIPATE FORMS AND COMPOSITIONS OF BIARYL INHIBITORS OF BRUTON'S TYROSINE KINASE

Nrf2 regulators

Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disorders

Amino compounds for treatment of immune and inflammatory disorders

Methods of treatment using pyrrolidinyl urea, thiourea, guanidine and cyanoguanidine compounds

Amino compounds for treatment of medical disorders

Herbicidal compounds

Organic light-emitting device

Organic electroluminescent device and manufacturing method thereof

Urinary polyamines as prostate cancer detection biomarkers

Azetidine-substituted fluorescent compounds

Pyrimidine-2,4-diamine derivatives for treatment of cancer

Substituted pyrazines as ATR kinase inhibitors

5-BROMO-INDIRUBINS

Π(PI)-conjugated compound, organic electroluminescence element material, light-emitting material, light-emitting thin film, organic electroluminescence element, display device, and illumination device

Salicylate inhibitors of MELK and methods of use

Pyrrolcarboxamide derivatives for the inhibition of ERK5

Substituted pyrazoles as IRAK inhibitors

Compound and organic light-emitting device including the same

Organic compound, and organic light-emitting diode and organic light-emitting diode display device including the same

ORGANIC LIGHT-EMITTING DEVICE AND COMPOUND

4,4-disubstituted cyclohexyl bridged heptamethine cyanine dyes and uses thereof

Materials for organic electroluminescent devices

Substituted heteroaryl compounds and methods of use

DNA-PK inhibitors

Inhibitors of Mc1-1 as drugs to overcome resistance to BRAF inhibitors and MEK inhibitors

Pyrimidine derivatives as kinase inhibitors and their therapeutical applications

Azasteroidal mimics

Cytotoxic peptides and conjugates thereof

Indazole inhibitors of the WNT signal pathway and therapeutic uses thereof

Heterocyclic compound and organic light emitting element comprising same

4-AMINOQUINAZOLIN COMPOUNDS AS PROLYL HYDROXYLASE INHIBITORS

Pyrazolyl-substituted heteroaryls and their use as medicaments

SUBSTITUTED QUINOXALINE DERIVATIVES

AMIDO-SUBSTITUTED CYCLOHEXANE DERIVATIVES

Substituted guanidines as fungicides

Substituted pyrazole compounds containing pyrimidine and preparation method and use thereof

Diamide macrocycles as factor XIa inhibitors

Indazoles and use thereof

Benzocyanine compounds

Compounds

Organic molecules, especially for use in organic optoelectronic devices

Oxindole compounds and pharmaceutical compositions thereof

BIHETEROARYL COMPOUNDS AND USES THEREOF

Organic electroluminescent element and electronic device

Indazole and azaindazole Btk inhibitors

Isoxazolyl substituted benzimidazoles